insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
Aparência
solid
Condições de armazenamento
Store at -20°C
Indicação
Gastrointestinal ulcer
Descrição do produto
Vonoprazan fumarate (Takecab®), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer,
